GUERBET: directors' dealings · France · AMF

About GUERBET

Guerbet is a French healthcare group and a recognized global specialist in medical imaging. The company focuses on contrast media, delivery systems, selected medical devices, and digital and AI-enabled solutions for diagnostic imaging and interventional radiology. Its roots go back to 1926, when the André Guerbet laboratory was founded, building on the legacy of Marcel Guerbet and the historical Lipiodol® product, which remains closely linked to the company’s heritage. Guerbet’s business model is centered on products that improve the quality, precision, and safety of imaging procedures. Its portfolio spans diagnostic imaging, including contrast agents for X-ray, MRI, ultrasound, and nuclear medicine, as well as interventional radiology, where its solutions help physicians visualize vessels and tissues and support minimally invasive procedures. The group is also moving further into digital healthcare, particularly through AI-based tools designed to make diagnosis faster and more accurate and to support clinical decision-making. The company has a broad international footprint, marketing its products in more than 114 countries and operating directly in more than 20 countries across Europe, Asia, Oceania, North America, and Latin America. At the end of 2025, Guerbet employed 2,746 people worldwide. Its innovation platform is supported by research and development centers in France, the United States, and Israel, and the group invests around 9% of sales in R&D, underscoring the science-intensive nature of the business. From a market perspective, Guerbet occupies a specialized position in a highly regulated and technically demanding industry. Demand is supported by the increasing use of imaging in oncology, neurology, vascular care, and other disciplines, while the company benefits from significant barriers to entry linked to product safety, regulatory approval, and clinical adoption. In 2024, Guerbet generated revenue of €841.1 million, up 9.0% at constant exchange rates and like-for-like, and materially improved profitability, highlighting the resilience of its core business and the contribution of product mix optimization, pricing discipline, and geographic diversification.